Linda Sealy - Publications

Affiliations: 
Vanderbilt University, Nashville, TN 
Area:
Molecular Biology, Cell Biology

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Abreu M, Sealy L. Cells expressing the C/EBPbeta isoform, LIP, engulf their neighbors. Plos One. 7: e41807. PMID 22860016 DOI: 10.1371/Journal.Pone.0041807  0.713
2012 Abreu MM, Sealy L. Abstract 4978: The C/EBPbeta isoform, liver-enriched inhibitory protein (LIP) induces cell death in breast cancer cell lines Cancer Research. 72: 4978-4978. DOI: 10.1158/1538-7445.Am2012-4978  0.709
2011 Atwood AA, Jerrell R, Sealy L. Negative regulation of C/EBPbeta1 by sumoylation in breast cancer cells. Plos One. 6: e25205. PMID 21980398 DOI: 10.1371/Journal.Pone.0025205  0.56
2011 Atwood AA, Sealy LJ. C/EBPβ's role in determining Ras-induced senescence or transformation. Small Gtpases. 2: 41-46. PMID 21686281 DOI: 10.4161/sgtp.2.1.15038  0.404
2011 Abreu MM, Sealy L. Abstract 2861: The C/EBPbeta isoform, liver-inhibitory protein (LIP), induces autophagy in breast cancer cell lines Cancer Research. 71: 2861-2861. DOI: 10.1158/1538-7445.Am2011-2861  0.695
2010 Russell A, Boone B, Jiang A, Sealy L. Genomic profiling of C/EBPβ2 transformed mammary epithelial cells: a role for nuclear interleukin-1β. Cancer Biology & Therapy. 10: 509-19. PMID 21057224 DOI: 10.4161/Cbt.10.5.12725  0.523
2010 Atwood AA, Sealy L. Regulation of C/EBPbeta1 by Ras in mammary epithelial cells and the role of C/EBPbeta1 in oncogene-induced senescence. Oncogene. 29: 6004-15. PMID 20818427 DOI: 10.1038/Onc.2010.336  0.585
2010 Abreu MM, Sealy L. The C/EBPbeta isoform, liver-inhibitory protein (LIP), induces autophagy in breast cancer cell lines. Experimental Cell Research. 316: 3227-38. PMID 20699097 DOI: 10.1016/J.Yexcr.2010.07.021  0.709
2005 Bundy L, Wells S, Sealy L. C/EBPbeta-2 confers EGF-independent growth and disrupts the normal acinar architecture of human mammary epithelial cells. Molecular Cancer. 4: 43. PMID 16371159 DOI: 10.1186/1476-4598-4-43  0.618
2005 Tripathi MK, Misra S, Khedkar SV, Hamilton N, Irvin-Wilson C, Sharan C, Sealy L, Chaudhuri G. Regulation of BRCA2 gene expression by the SLUG repressor protein in human breast cells. The Journal of Biological Chemistry. 280: 17163-71. PMID 15734731 DOI: 10.1074/Jbc.M501375200  0.434
2003 Eaton EM, Sealy L. Modification of CCAAT/enhancer-binding protein-beta by the small ubiquitin-like modifier (SUMO) family members, SUMO-2 and SUMO-3. The Journal of Biological Chemistry. 278: 33416-21. PMID 12810706 DOI: 10.1074/Jbc.M305680200  0.751
2003 Qiao L, Han SI, Fang Y, Park JS, Gupta S, Gilfor D, Amorino G, Valerie K, Sealy L, Engelhardt JF, Grant S, Hylemon PB, Dent P. Bile acid regulation of C/EBPbeta, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes. Molecular and Cellular Biology. 23: 3052-66. PMID 12697808 DOI: 10.1128/Mcb.23.9.3052-3066.2003  0.543
2003 Bundy LM, Sealy L. CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture. Oncogene. 22: 869-83. PMID 12584567 DOI: 10.1038/Sj.Onc.1206216  0.609
2002 Duong DT, Waltner-Law ME, Sears R, Sealy L, Granner DK. Insulin inhibits hepatocellular glucose production by utilizing liver-enriched transcriptional inhibitory protein to disrupt the association of CREB-binding protein and RNA polymerase II with the phosphoenolpyruvate carboxykinase gene promoter. The Journal of Biological Chemistry. 277: 32234-42. PMID 12070172 DOI: 10.1074/Jbc.M204873200  0.412
2001 Eaton EM, Hanlon M, Bundy L, Sealy L. Characterization of C/EBPbeta isoforms in normal versus neoplastic mammary epithelial cells. Journal of Cellular Physiology. 189: 91-105. PMID 11573208 DOI: 10.1002/Jcp.1139  0.691
2001 Hanlon M, Sturgill TW, Sealy L. ERK2- and p90Rsk2-dependent Pathways Regulate the CCAAT/Enhancer-binding Protein-β Interaction with Serum Response Factor Journal of Biological Chemistry. 276: 38449-38456. PMID 11500490 DOI: 10.1074/Jbc.M102165200  0.77
2000 Hanlon M, Bundy LM, Sealy L. C/EBP beta and Elk-1 synergistically transactivate the c-fos serum response element. Bmc Cell Biology. 1: 2. PMID 11151091 DOI: 10.1186/1471-2121-1-2  0.785
2000 Mobley CM, Sealy L. The Rous sarcoma virus long terminal repeat promoter is regulated by TFII-I. Journal of Virology. 74: 6511-9. PMID 10864664 DOI: 10.1128/Jvi.74.14.6511-6519.2000  0.391
1999 Liao J, Piwien-Pilipuk G, Ross SE, Hodge CL, Sealy L, MacDougald OA, Schwartz J. CCAAT/enhancer-binding protein β (C/EBPβ) and C/EBPδ contribute to growth hormone-regulated transcription of c-fos Journal of Biological Chemistry. 274: 31597-31604. PMID 10531366 DOI: 10.1074/Jbc.274.44.31597  0.51
1999 Hanlon M, Sealy L. Ras regulates the association of serum response factor and CCAAT/enhancer-binding protein beta. The Journal of Biological Chemistry. 274: 14224-8. PMID 10318842 DOI: 10.1074/Jbc.274.20.14224  0.787
1998 Mobley CM, Sealy L. Role of the transcription start site core region and transcription factor YY1 in Rous sarcoma virus long terminal repeat promoter activity. Journal of Virology. 72: 6592-601. PMID 9658104 DOI: 10.1128/Jvi.72.8.6592-6601.1998  0.386
1997 Sealy L, Malone D, Pawlak M. Regulation of the cfos serum response element by C/EBPbeta. Molecular and Cellular Biology. 17: 1744-55. PMID 9032301 DOI: 10.1128/Mcb.17.3.1744  0.445
1994 Sears RC, Sealy L. Multiple forms of C/EBP beta bind the EFII enhancer sequence in the Rous sarcoma virus long terminal repeat. Molecular and Cellular Biology. 14: 4855-71. PMID 8007984 DOI: 10.1128/Mcb.14.7.4855  0.507
1994 Hann SR, Dixit M, Sears RC, Sealy L. The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site. Genes & Development. 8: 2441-52. PMID 7958908 DOI: 10.1101/Gad.8.20.2441  0.586
1994 Briggs R, Briggs J, Ozer J, Sealy L, Dworkin L, Kingsmore S, Seldin M, Kaur G, Athwal R, Dessypris E. The human myeloid cell nuclear differentiation antigen gene is one of at least two related interferon-inducible genes located on chromosome 1q that are expressed specifically in hematopoietic cells Blood. 83: 2153-2162. DOI: 10.1182/Blood.V83.8.2153.2153  0.326
1993 Ozer J, Chalkley R, Sealy L. Isolation of the CCAAT transcription factor subunit EFIA cDNA and a potentially functional EFIA processed pseudogene from Bos taurus: insights into the evolution of the EFIA/dbpB/YB-1 gene family. Gene. 124: 223-30. PMID 8444345 DOI: 10.1016/0378-1119(93)90397-L  0.303
1992 Boulden AM, Sealy LJ. Maximal serum stimulation of the c-fos serum response element requires both the serum response factor and a novel binding factor, SRE-binding protein. Molecular and Cellular Biology. 12: 4769-83. PMID 1328862 DOI: 10.1128/MCB.12.10.4769  0.386
1992 Sears RC, Sealy L. Characterization of nuclear proteins that bind the EFII enhancer sequence in the Rous sarcoma virus long terminal repeat. Journal of Virology. 66: 6338-52. PMID 1328670 DOI: 10.1128/Jvi.66.11.6338-6352.1992  0.499
1990 Greuel BT, Sealy L, Majors JE. Transcriptional activity of the Rous sarcoma virus long terminal repeat correlates with binding of a factor to an upstream CCAAT box in vitro. Virology. 177: 33-43. PMID 2162108 DOI: 10.1016/0042-6822(90)90457-3  0.383
1990 Boulden A, Sealy L. Identification of a third protein factor which binds to the Rous sarcoma virus LTR enhancer: possible homology with the serum response factor. Virology. 174: 204-16. PMID 2152992 DOI: 10.1016/0042-6822(90)90069-4  0.441
1989 Sealy L, Burgess RR, Cotten M, Chalkley R. Purification of Xenopus egg nucleoplasmin and its use in chromatin assembly in vitro Methods in Enzymology. 170: 612-630. PMID 2549340 DOI: 10.1016/0076-6879(89)70068-9  0.333
1979 Rubenstein P, Sealy L, Marshall S, Chalkley R. Cellular protein synthesis and inhibition of cell division are independent of butyrate-induced histone hyperacetylation. Nature. 280: 692-3. PMID 471049 DOI: 10.1038/280692A0  0.329
1979 Moore M, Jackson V, Sealy L, Chalkley R. Comparative studies on highly metabolically active histone acetylation. Biochimica Et Biophysica Acta. 561: 248-60. PMID 105758 DOI: 10.1016/0005-2787(79)90508-2  0.33
1978 Nelson DA, Perry M, Sealy L, Chalkley R. DNAse I preferentially digests chromatin containing hyperacetylated histones. Biochemical and Biophysical Research Communications. 82: 1346-53. PMID 697799 DOI: 10.1016/0006-291X(78)90337-6  0.316
Show low-probability matches.